Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing medicine for treating chilblain

A technology for medicine and frostbite, which is applied in the field of preparation of medicines for the treatment of frostbite, can solve the problems of reducing vascular permeability, long treatment time, unsatisfactory effect, etc., and achieves the effects of increasing medication time, small medication amount, and saving time and money. Effect

Inactive Publication Date: 2010-08-18
张永刚
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, it has been proved by medicine that the root cause of frostbite is that when the smooth muscle in the subcutaneous vein capillary at the far end of the body spasms when it encounters low temperature, it will reduce the permeability of the blood vessel, causing the blood vessel to stagnate and cause frostbite. This is the fundamental reason why chilblain will show bruises. At present, it is commonly used in the treatment of chilblains. The treatment time is long and the effect is not satisfactory.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] The preparation method of the medicine of the present invention is characterized in that the following components by weight and number are used:

[0030] 1 part of troxerutin injection, 8 parts of atropine sulfate injection, 4 parts of gentamicin sulfate injection and 2 parts of chlorpheniramine maleate injection, the troxerutin injection: 100mg / 2ml; described atropine sulfate injection: 1mg / 2ml (2ml: 1mg); described gentamicin sulfate injection: 2ml: 80,000 units; described chlorpheniramine maleate injection specification content : 1ml: 10mg.

[0031] The preparation is made by putting troxerutin injection, atropine sulfate injection, gentamicin sulfate injection and chlorpheniramine maleate injection into a sterile container and shaking them evenly.

[0032] The medicinal liquid of the present invention is quantitatively divided into 10mL medical plastic bottles or spray-type plastic bottles according to different requirements, sealed with an upper cover, inspected ...

Embodiment 2

[0034] The preparation method of the medicine of the present invention is characterized in that the following components by weight and number are used:

[0035] 1.5 parts of troxerutin injection, 5 parts of atropine sulfate injection, 3 parts of gentamicin sulfate injection and 1 part of chlorpheniramine maleate injection, the troxerutin injection: 100mg / 2ml; described atropine sulfate injection: 1mg / 2ml (2ml: 1mg); described gentamicin sulfate injection: 2ml: 80,000 units; described chlorpheniramine maleate injection specification content : 1ml: 10mg.

[0036] The preparation is made by putting troxerutin injection, atropine sulfate injection, gentamicin sulfate injection and chlorpheniramine maleate injection into a sterile container and shaking them evenly.

[0037] The medicinal liquid of the present invention is quantitatively divided into 20mL medical plastic bottles or spray-type plastic bottles according to different requirements, sealed with an upper cover, inspecte...

Embodiment 3

[0039] The preparation method of the medicine of the present invention is characterized in that the following components by weight and number are used:

[0040] 2 parts of troxerutin injection, 10 parts of atropine sulfate injection, 2 parts of gentamicin sulfate injection and 1.5 parts of chlorpheniramine maleate injection, described troxerutin injection: 100mg / 2ml; described atropine sulfate injection: 1mg / 2ml (2ml: 1mg); described gentamicin sulfate injection: 2ml: 80,000 units; described chlorpheniramine maleate injection specification content : 1ml: 10mg.

[0041] The preparation is made by putting troxerutin injection, atropine sulfate injection, gentamicin sulfate injection and chlorpheniramine maleate injection into a sterile container and shaking them evenly.

[0042] The medicinal liquid of the present invention is quantitatively divided into 30mL medical plastic bottles or spray-type plastic bottles according to different requirements, sealed with an upper cover, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a method for preparing a medicine for treating chilblain. The method adopts the following components in part by weight: 1 to 2 parts of troxerutin injection, 5 to 10 parts of atropine sulfate injection, 2 to 5 parts of gentamycin sulfate and 1 to 2 parts of chlorphenamine maleate injection; the troxerutin injection is 100mg / 2ml, the atropine sulfate injection is 1mg / 2ml (2ml:1mg); the gentamycin sulfate is 2ml:80,000 unit, and the specified content of the chlorphenamine maleate injection is 1ml:10mg; and the troxerutin injection, the atropine sulfate injection, the gentamycin sulfate and the chlorphenamine maleate injection are poured into a sterile container and uniformly agitated, so that the medicine is prepared. The invention can effectively relieve vascular smooth muscle spasm, recover the permeability of venous capillaries, enhance blood circulation and eliminate oedema and also has the effects of diminishing inflammation, easing pain and relieving itching.

Description

technical field [0001] The invention relates to a preparation method of medicine for treating frostbite Background technique [0002] Frostbite is the localized inflammatory damage caused by cold, and frostbite is a common disease in winter. According to relevant statistics, there are 200 million people in my country who suffer from frostbite every year, mainly children, women and the elderly. Motherland medicine has discussed this for a long time: "In the month of severe winter, when exposed to wind, snow, cold and poisonous air, it hurts the skin, stagnation of Qi and blood, and frostbite occurs, and the skin and flesh rot, and in severe cases, the branches will fall", that is to say The pathogenesis of this disease mainly has two aspects, one is cold external attack, especially frostbite when there is damp and windy; At present, it has been proved by medicine that the root cause of frostbite is that when the smooth muscle in the subcutaneous vein capillary at the far end...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61P17/02A61K31/7036A61K31/46A61K31/4402
Inventor 张永刚刘丽红张鎏岩
Owner 张永刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products